Mode
Text Size
Log in / Sign up

Recurrent Clostridium difficile infection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Recurrent Clostridium difficile infection

5 trials tracked for Recurrent Clostridium difficile infection: 1 in phase 3 or 4.

5Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 3 Other / NA 1
  1. Phase 3 Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin Completed
  2. Phase 2 Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection Completed
  3. Phase 2 Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection Completed
  4. Phase 2 Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea Completed
  5. N/A Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.